DK110190A - Alveolaere surfaktantproteiner - Google Patents

Alveolaere surfaktantproteiner Download PDF

Info

Publication number
DK110190A
DK110190A DK110190A DK110190A DK110190A DK 110190 A DK110190 A DK 110190A DK 110190 A DK110190 A DK 110190A DK 110190 A DK110190 A DK 110190A DK 110190 A DK110190 A DK 110190A
Authority
DK
Denmark
Prior art keywords
alveolary
surfactant proteins
human
peptides
surfactant
Prior art date
Application number
DK110190A
Other languages
English (en)
Other versions
DK175843B1 (da
DK110190D0 (da
Inventor
Bradley J Benson
Robert T White
Jr James W Schilling
Douglas Buckley
Robert M Scarborough
Barbara Cordell
Original Assignee
California Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Biotechnology Inc filed Critical California Biotechnology Inc
Publication of DK110190D0 publication Critical patent/DK110190D0/da
Publication of DK110190A publication Critical patent/DK110190A/da
Application granted granted Critical
Publication of DK175843B1 publication Critical patent/DK175843B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Seasonings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
DK199001101A 1987-11-04 1990-05-03 Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet DK175843B1 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11709987A 1987-11-04 1987-11-04
US26644388A 1988-11-01 1988-11-01
PCT/US1988/003899 WO1989004326A1 (en) 1987-11-04 1988-11-02 Alveolar surfactant proteins

Publications (3)

Publication Number Publication Date
DK110190D0 DK110190D0 (da) 1990-05-03
DK110190A true DK110190A (da) 1990-07-04
DK175843B1 DK175843B1 (da) 2005-03-29

Family

ID=26814915

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199001101A DK175843B1 (da) 1987-11-04 1990-05-03 Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet

Country Status (9)

Country Link
EP (1) EP0383837B1 (da)
JP (1) JP2602968B2 (da)
KR (2) KR960010558B1 (da)
AT (1) ATE163013T1 (da)
AU (1) AU625394B2 (da)
CA (1) CA1340461C (da)
DK (1) DK175843B1 (da)
IL (1) IL88293A0 (da)
WO (1) WO1989004326A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104853A (en) * 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
US5164369A (en) * 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
AU4216689A (en) * 1988-08-11 1990-03-05 California Biotechnology, Inc. Method for stabilizing heterologous protein expression and vectors for use therein
CA2063273C (en) * 1989-07-11 2002-09-24 Bradley J. Benson Surfactant compositions and methods
US5258496A (en) * 1990-07-10 1993-11-02 Scios Nova Inc. Isolation and purification of lung surfactant protein
US5272252A (en) * 1991-11-04 1993-12-21 Merrell Dow Pharmaceuticals Inc. Synthetic lung surfactant having antioxidant properties
DK0733645T3 (da) * 1993-12-08 2003-07-14 Mitsubishi Pharma Corp Syntetisk peptid, lungeoverfladeaktivt stof indeholdende dette og præparat mod respiratory distress syndrome
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
AU4908799A (en) 1998-07-24 2000-02-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Determination of the hydrophobic pulmonary surfactant protein sp-c
DE60032769T2 (de) 1999-06-17 2007-11-22 Nycomed Gmbh Surfactant PROTEIN C ESTER
US7053176B1 (en) 1999-09-16 2006-05-30 Altana Pharma Ag Combination of C1-INH and lung surfactant for the treatment of respiratory disorders
AU2002338882B2 (en) 2001-10-11 2008-04-03 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. Novel use of pulmonary surfactant
AU2002357168A1 (en) 2001-12-12 2003-07-09 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
CA2575513C (en) 2004-08-06 2014-09-16 Altana Pharma Ag Composition comprising a pulmonary surfactant and a tnf-derived peptide
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
SI1841458T1 (sl) 2005-01-06 2012-04-30 Discovery Lab Inc Zdravljenje s predpisanim odmerjanjem surfaktanta za zdravljenje ali preprečevanje bronhopulmonalne displazije
EP2063903A1 (en) 2006-09-19 2009-06-03 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
EP2303314B1 (en) 2008-06-25 2013-12-11 Braasch Biotech LLC Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof in cattle
NZ590010A (en) 2008-06-25 2013-01-25 Braasch Biotech Llc Compositions and methods treating growth hormone deficiency and/or an insulin-like growth factor 1 deficiency with somatostatin and an adjuvant
WO2010068754A2 (en) 2008-12-10 2010-06-17 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation
US10441652B2 (en) 2014-08-21 2019-10-15 Braasch Biotech Llc Methods for improving immunological response in vaccinated animals
DE102016125491A1 (de) 2016-12-22 2018-06-28 Bombardier Transportation Gmbh Zugverband mit mindestens einer Aufhängungsvorrichtung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56026B1 (en) * 1982-10-19 1991-03-27 Cetus Corp Cysteine-depleted muteins of biologically active proteins
WO1988003170A1 (en) * 1986-10-24 1988-05-05 Whitsett Jeffrey A Pulmonary hydrophobic surfactant-associated proteins

Also Published As

Publication number Publication date
WO1989004326A1 (en) 1989-05-18
EP0383837A1 (en) 1990-08-29
KR960010558B1 (ko) 1996-08-02
CA1340461C (en) 1999-03-23
EP0383837B1 (en) 1998-02-04
DK175843B1 (da) 2005-03-29
ATE163013T1 (de) 1998-02-15
AU2797989A (en) 1989-06-01
JP2602968B2 (ja) 1997-04-23
JPH03502095A (ja) 1991-05-16
IL88293A0 (en) 1989-06-30
DK110190D0 (da) 1990-05-03
EP0383837A4 (en) 1991-09-11
AU625394B2 (en) 1992-07-09
KR900700505A (ko) 1990-08-13

Similar Documents

Publication Publication Date Title
DK110190D0 (da) Alveolaere surfaktantproteiner
ATE140963T1 (de) Verfahren zur herstellung von sekretierten rezeptoranalogen
FI884051L (fi) Menetelmä stabiloitujen humaaniproteiinivalmisteiden valmistamiseksi
NO831317L (no) Fremgangsmaate for fremstilling av funksjonelle menneske-urokinase proteiner.
ATE122357T1 (de) Polypeptide mit hormonwachstumsbefreiender wirkung.
ATE113607T1 (de) Polypeptidverbindungen mit wachstumshormonfreisetzender aktivität.
KR870700019A (ko) 재조합 폐포 계면활성 단백질
NL300062I2 (nl) Osteogene middelen.
DE3885459D1 (de) Molkeproteinfraktionen.
EP0751992A4 (en) VASCULAR ENDOTHELIAL GROWTH FACTOR 2
DE3750342D1 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
CA2083177A1 (en) Alveolar surfactant proteins
PT87688A (pt) Hybrid protein c and method for its preparation
FI893724A7 (fi) Hybridiproteiini C:n rakenteet ja menetelmät niiden valmistamiseksi
ES2072490T3 (es) Procedimiento para la pasteurizacion de la proteina tisular pp4.
DK109590A (da) Biologisk aktivt protein
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
NO891926D0 (no) Fremgangsmaate for fremstilling av stabile protein- eller peptidpreparater.
NO881942D0 (no) Fremgangsmaate for fremstilling av fremmede proteiner i streptomyceten.
NO874320D0 (no) Fremgangsmaate for bestemmelse av funksjonelle nivaaer av protein c i humant plasma.
SE8702724D0 (sv) Proteins and protein compositions and their use
LV10393A (lv) Savietojams cilveka olbaltumvielas preparats
NO173340C (no) Humant protein C antistoff
ATE96618T1 (de) Molkeproteinfraktionen.
DK362088D0 (da) Fusionsproteiner og fusionsproteinpartikler

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK